| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 1 | 6 | |
| BREAST | 982 | 12 | 626 | 88 | 1071 | 210 | 1278 |
| ERLYTX | 95 | 0 | 0 | 5 | 61 | 14 | 85 |
| GI | 195 | 3 | 157 | 15 | 183 | 31 | 189 |
| GU | 442 | 6 | 313 | 35 | 426 | 69 | 420 |
| LEUK | 140 | 4 | 209 | 12 | 146 | 26 | 158 |
| LUNG | 218 | 5 | 261 | 19 | 231 | 31 | 189 |
| LYMPH | 394 | 6 | 313 | 34 | 414 | 66 | 402 |
| MELAN | 297 | 0 | 0 | 1 | 12 | 1 | 6 |
| MMYEL | 166 | 0 | 0 | 5 | 61 | 15 | 91 |
| MULT | 19 | 2 | 104 | 8 | 97 | 15 | 91 |
| OTHER | 40 | 0 | 0 | 4 | 49 | 6 | 37 |
| PREV | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
| SXQOL | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2995 | 38 | 1983 | 226 | 2751 | 485 | 2952 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 116 | 2 | 104 | 13 | 158 | 26 | 158 |
| ERLYTX | 10 | 0 | 0 | 0 | 0 | 1 | 6 |
| LEUK | 668 | 9 | 470 | 49 | 597 | 100 | 609 |
| LUNG | 299 | 8 | 417 | 32 | 390 | 71 | 432 |
| LYMPH | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| OTHER | 36 | 2 | 104 | 9 | 110 | 12 | 73 |
| PEOLC | 122 | 5 | 261 | 18 | 219 | 36 | 219 |
| PREV | 221 | 5 | 261 | 19 | 231 | 40 | 244 |
| SURV | 19 | 1 | 52 | 4 | 49 | 8 | 49 |
| SXQOL | 585 | 12 | 626 | 51 | 621 | 104 | 633 |
| Total | 2077 | 44 | 2295 | 195 | 2375 | 398 | 2423 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 1 | 6 | |
| BREAST | 982 | 12 | 626 | 88 | 1071 | 210 | 1278 |
| CCD | 116 | 2 | 104 | 13 | 158 | 26 | 158 |
| ERLYTX | 105 | 0 | 0 | 5 | 61 | 15 | 91 |
| GI | 195 | 3 | 157 | 15 | 183 | 31 | 189 |
| GU | 442 | 6 | 313 | 35 | 426 | 69 | 420 |
| LEUK | 808 | 13 | 678 | 61 | 743 | 126 | 767 |
| LUNG | 517 | 13 | 678 | 51 | 621 | 102 | 621 |
| LYMPH | 395 | 6 | 313 | 34 | 414 | 66 | 402 |
| MELAN | 297 | 0 | 0 | 1 | 12 | 1 | 6 |
| MMYEL | 166 | 0 | 0 | 5 | 61 | 15 | 91 |
| MULT | 19 | 2 | 104 | 8 | 97 | 15 | 91 |
| OTHER | 76 | 2 | 104 | 13 | 158 | 18 | 110 |
| PEOLC | 122 | 5 | 261 | 18 | 219 | 36 | 219 |
| PREV | 224 | 5 | 261 | 19 | 231 | 40 | 244 |
| SURV | 19 | 1 | 52 | 4 | 49 | 8 | 49 |
| SXQOL | 587 | 12 | 626 | 51 | 621 | 104 | 633 |
| Total | 5072 | 82 | 4277 | 421 | 5125 | 883 | 5375 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 1 | 6 | |
| BREAST | 604 | 9 | 470 | 55 | 670 | 134 | 816 |
| ERLYTX | 52 | 0 | 0 | 3 | 37 | 9 | 55 |
| GI | 143 | 2 | 104 | 13 | 158 | 22 | 134 |
| GU | 370 | 5 | 261 | 23 | 280 | 50 | 304 |
| LEUK | 86 | 2 | 104 | 7 | 85 | 15 | 91 |
| LUNG | 136 | 1 | 52 | 10 | 122 | 15 | 91 |
| LYMPH | 253 | 6 | 313 | 26 | 317 | 43 | 262 |
| MELAN | 188 | 0 | 0 | 1 | 12 | 1 | 6 |
| MMYEL | 105 | 0 | 0 | 3 | 37 | 7 | 43 |
| MULT | 7 | 0 | 0 | 2 | 24 | 5 | 30 |
| OTHER | 40 | 0 | 0 | 4 | 49 | 6 | 37 |
| PREV | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
| SXQOL | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1991 | 25 | 1304 | 147 | 1791 | 308 | 1875 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 103 | 2 | 104 | 11 | 134 | 22 | 134 |
| ERLYTX | 10 | 0 | 0 | 0 | 0 | 1 | 6 |
| LEUK | 308 | 4 | 209 | 26 | 317 | 47 | 286 |
| LUNG | 182 | 4 | 209 | 19 | 231 | 43 | 262 |
| LYMPH | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| OTHER | 36 | 2 | 104 | 9 | 110 | 12 | 73 |
| PEOLC | 86 | 4 | 209 | 14 | 170 | 27 | 164 |
| PREV | 221 | 5 | 261 | 19 | 231 | 40 | 244 |
| SURV | 19 | 1 | 52 | 4 | 49 | 8 | 49 |
| SXQOL | 395 | 10 | 522 | 31 | 377 | 65 | 396 |
| Total | 1361 | 32 | 1670 | 133 | 1619 | 265 | 1614 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 1 | 6 | |
| BREAST | 789 | 8 | 417 | 66 | 804 | 160 | 974 |
| CCD | 138 | 3 | 157 | 12 | 146 | 32 | 195 |
| ERLYTX | 62 | 0 | 0 | 3 | 37 | 10 | 61 |
| GI | 149 | 2 | 104 | 13 | 158 | 25 | 152 |
| GU | 391 | 7 | 365 | 26 | 317 | 55 | 335 |
| LEUK | 394 | 6 | 313 | 33 | 402 | 62 | 377 |
| LUNG | 319 | 5 | 261 | 29 | 353 | 58 | 353 |
| LYMPH | 254 | 6 | 313 | 26 | 317 | 43 | 262 |
| MELAN | 188 | 0 | 0 | 1 | 12 | 1 | 6 |
| MMYEL | 102 | 0 | 0 | 3 | 37 | 7 | 43 |
| MULT | 21 | 0 | 0 | 5 | 61 | 7 | 43 |
| OTHER | 253 | 6 | 313 | 23 | 280 | 48 | 292 |
| PEOLC | 94 | 3 | 157 | 14 | 170 | 27 | 164 |
| PREV | 224 | 5 | 261 | 19 | 231 | 40 | 244 |
| SURV | 19 | 1 | 52 | 4 | 49 | 8 | 49 |
| SXQOL | 397 | 10 | 522 | 31 | 377 | 65 | 396 |
| Total | 3796 | 62 | 3235 | 308 | 3751 | 649 | 3952 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 836 | 10 | 522 | 70 | 852 | 164 | 998 |
| ERLYTX | 91 | 0 | 0 | 5 | 61 | 12 | 73 |
| GI | 110 | 3 | 157 | 9 | 110 | 21 | 128 |
| GU | 250 | 4 | 209 | 23 | 280 | 45 | 274 |
| LEUK | 109 | 3 | 157 | 10 | 122 | 21 | 128 |
| LUNG | 187 | 4 | 209 | 16 | 195 | 27 | 164 |
| LYMPH | 318 | 3 | 157 | 26 | 317 | 53 | 323 |
| MMYEL | 155 | 0 | 0 | 4 | 49 | 14 | 85 |
| MULT | 19 | 2 | 104 | 8 | 97 | 15 | 91 |
| Total | 2075 | 29 | 1515 | 171 | 2083 | 372 | 2264 |
| Inst. | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| Member | 1970 | 33 | 1722 | 173 | 2106 | 350 | 2131 |
| AFFIL | 122 | 5 | 261 | 16 | 195 | 27 | 164 |
| CCOP/NCORP | 1260 | 19 | 991 | 91 | 1108 | 196 | 1193 |
| Non-SWOG | 1720 | 25 | 1304 | 141 | 1717 | 310 | 1887 |
| Total | 5072 | 82 | 4278 | 421 | 5126 | 883 | 5375 |
| ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
|---|---|---|---|---|---|
| MMYEL | S2005 | WM, Prev. Untreated, I/R +/- Venetoclax | 1 | T | 20-NOV-25 |
| ADMIN | STUDYID | STNAME | REGTYPE | Registrations |
|---|---|---|---|---|
| LEUK | MYELOMATCH | MSRP for the NCI myeloMATCH Clinical Trials | 1 | 9 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 1 | 8 |
| SXQOL | S2205 | ICE COMPRESS: Reduction of CIPN from Taxanes | 1 | 8 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 2 | 7 |
| BREAST | S2212 | Breast, TNBC, Neoadj Chemo + Pembro | 1 | 7 |
| OTHER | 10323 | Moonshot Biobank Research | 1 | 4 |
| PREV | A212102 | Blind Ref Set for Multicancer Early Detection | 1 | 4 |
| GU | S1931 | RENAL, Stg IV, IO + Nephrectomy. vs IO Only | 1 | 3 |
| SXQOL | S2013 | I-CHECKIT: ICI toxicity risk prediction study | 1 | 3 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 2 | 3 |
| GI | S2303 | Gas/Esoph/GEJ, Adv, Ram + Pac +/- Nivo | 1 | 3 |
| PEOLC | S2408 | Panc Fistula Prevention, Lanreotide | 1 | 3 |